Suchergebnisse - "Koizumi, Yusuke"

PubPharm (159)

101

Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2017

von Yamagishi, Y. | Mikamo, H. | Kato, H. | +7

102

Colistin loading dose enhanced antimicrobial activity for in vivo mouse thigh infection model with Pseudomonas aeruginosa with highly antimicrobial resistant

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2017

von Hagihara, M. | Kato, H. | Hirai, J. | +6

103

Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2017

von Kato, H. | Hagihara, M. | Nishiyama, N. | +4

104

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen

enthalten in: Drugs in R&D | 2017

von Kato, H. | Hagihara, M. | Hirai, J. | +7

105

Clinical effectiveness of daptomycin loading dose in patients infected with Gram-positive pathogens

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2017

von Kato, H. | Hagihara, M. | Nishiyama, N. | +4

106

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen

enthalten in: Drugs in R & D | 2017

von Kato, H. | Hagihara, M. | Hirai, J. | +7

107

In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa

enthalten in: Chemotherapy | 2017

von Yamagishi, Y. | Hagihara, M. | Kato, H. | +7

108

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen

enthalten in: Drugs in R & D | 2017

von Kato, H. | Hagihara, M. | Hirai, J. | +7

109

Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients

enthalten in: BMC infectious diseases | 2017

von Koizumi, Y. | Shimizu, K. | Shigeta, M. | +8

110

Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients

enthalten in: BMC infectious diseases | 2017

von Koizumi, Y. | Shimizu, K. | Shigeta, M. | +8